Correlation Between Molecular Pharmacology and Neurobiological Technologies
Can any of the company-specific risk be diversified away by investing in both Molecular Pharmacology and Neurobiological Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Pharmacology and Neurobiological Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Pharmacology and Neurobiological Technologies, you can compare the effects of market volatilities on Molecular Pharmacology and Neurobiological Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Pharmacology with a short position of Neurobiological Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Pharmacology and Neurobiological Technologies.
Diversification Opportunities for Molecular Pharmacology and Neurobiological Technologies
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Molecular and Neurobiological is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Pharmacology and Neurobiological Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobiological Technologies and Molecular Pharmacology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Pharmacology are associated (or correlated) with Neurobiological Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobiological Technologies has no effect on the direction of Molecular Pharmacology i.e., Molecular Pharmacology and Neurobiological Technologies go up and down completely randomly.
Pair Corralation between Molecular Pharmacology and Neurobiological Technologies
If you would invest 0.01 in Neurobiological Technologies on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Neurobiological Technologies or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 1.59% |
| Values | Daily Returns |
Molecular Pharmacology vs. Neurobiological Technologies
Performance |
| Timeline |
| Molecular Pharmacology |
| Neurobiological Technologies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Molecular Pharmacology and Neurobiological Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Pharmacology and Neurobiological Technologies
The main advantage of trading using opposite Molecular Pharmacology and Neurobiological Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Pharmacology position performs unexpectedly, Neurobiological Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobiological Technologies will offset losses from the drop in Neurobiological Technologies' long position.| Molecular Pharmacology vs. Curative Biotechnology | Molecular Pharmacology vs. Kineta Inc | Molecular Pharmacology vs. Vertex Pharmaceuticals | Molecular Pharmacology vs. BioNTech SE |
| Neurobiological Technologies vs. Pharming Group NV | Neurobiological Technologies vs. Kane Biotech | Neurobiological Technologies vs. Health Sciences Gr | Neurobiological Technologies vs. MedMira |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |